Talphera, Inc. (NASDAQ:TLPH – Get Free Report)’s share price shot up 1.7% during mid-day trading on Tuesday . The company traded as high as $1.02 and last traded at $0.95. 20,477 shares traded hands during mid-day trading, a decline of 83% from the average session volume of 119,366 shares. The stock had previously closed at $0.93.
Wall Street Analysts Forecast Growth
Separately, HC Wainwright reiterated a “buy” rating and issued a $6.00 target price on shares of Talphera in a research report on Thursday, March 7th.
Read Our Latest Research Report on TLPH
Talphera Price Performance
Talphera (NASDAQ:TLPH – Get Free Report) last posted its quarterly earnings data on Wednesday, March 6th. The company reported ($0.25) EPS for the quarter, missing analysts’ consensus estimates of ($0.24) by ($0.01). The company had revenue of $0.28 million during the quarter. Sell-side analysts expect that Talphera, Inc. will post -1.12 earnings per share for the current year.
About Talphera
Talphera, Inc, a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit.
Recommended Stories
- Five stocks we like better than Talphera
- What is the NASDAQ Stock Exchange?
- Charles Schwab Fortifies its Uptrend on EPS Beat
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Lockheed Martin Stock Aims for a Fresh All-Time High
- Investing in the High PE Growth Stocks
- Beyond the Halving: The Future of Bitcoin Mining Stocks
Receive News & Ratings for Talphera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Talphera and related companies with MarketBeat.com's FREE daily email newsletter.